Cipla Limited — research summary
Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Cipla Limited, explained in plain English.
- Cipla Limited is tracked in the Pharma & Healthcare sector of our NSE large-cap universe.
- Reported fundamentals show a net margin of 12.01%, debt to equity of 1.78.
- Our transparent MaxGrade checklist scores it F (16/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
- Annualised volatility over the past year is 20.83% with a maximum drawdown of -28.32% and a beta of 0.6 against NIFTY 50.
- Recent coverage: ICICI Lombard, United Breweries And Cipla: Three Stocks That Bucked The Trend As Stock Market Crashed
Figures from the current session. Market open.
Loading CIPLA…